Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A416MF | ISIN: US09061H4065 | Ticker-Symbol:
NASDAQ
06.06.25 | 20:17
3,320 US-Dollar
+6,41 % +0,200
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
BIOMERICA INC Chart 1 Jahr
5-Tage-Chart
BIOMERICA INC 5-Tage-Chart

Aktuelle News zur BIOMERICA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrBiomerica beruft Eric B. Chin in den Vorstand2
FrBiomerica, Inc.: Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair1
FrBIOMERICA INC - 8-K, Current Report1
BIOMERICA Aktie jetzt für 0€ handeln
DoBiomerica, Inc.: Biomerica's inFoods IBS Clinical Study Results Published in June Issue of Gastroenterology1
22.05.Biomerica, Inc.: Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods IBS using a First of Its Kind Real-Time IBS Patient Feedback System2
07.05.Biomerica, Inc.: PLA Code Application Filed for inFoods IBS Test - A Key Step Toward Reimbursement2
23.04.Biomerica, Inc.: United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel Ulcer Test for Detection of H. pylori Infection1
17.04.Biomerica's kidney disease test approved for UAE market3
17.04.Biomerica, Inc.: United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel Kidney Disease Test for Early Detection of Kidney Damage2
16.04.Biomerica Announced 1-for-8 Reverse Stock Split2
16.04.Biomerica stock plummets on 1-for-8 reverse stock split4
16.04.Biomerica, Inc.: Biomerica Announces Reverse Stock Split193IRVINE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) ("Biomerica"), a global provider of advanced medical products, today announced that it will implement a 1-for-8 reverse...
► Artikel lesen
16.04.BIOMERICA INC - 8-K, Current Report1
15.04.Biomerica GAAP EPS of -$1.20, revenue of $1.1M2
15.04.Biomerica, Inc.: Biomerica Reports Third Quarter Fiscal 2025 Financial Results193Total Revenue Increases 10% Year-Over-YearDelivers Improved Gross Margins, Achieves Annual Cost Savings Target Early, and Reduces Cash Burn Over 55% IRVINE, Calif., April 15, 2025 (GLOBE NEWSWIRE)...
► Artikel lesen
14.04.BIOMERICA INC - 10-Q, Quarterly Report2
26.02.Biomerica gains EU certification for IBD food intolerance products1
26.02.Biomerica erhält EU-Zertifizierung für Nahrungsmittelunverträglichkeitsprodukte bei CED1
26.02.Biomerica, Inc.: Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn's Disease and Ulcerative Colitis150Significant Milestone: Biomerica secures IVDR (In Vitro Diagnostic Regulation) certification, ensuring compliance with stringent European Union standards and allowing sales of the products in the...
► Artikel lesen
19.02.Biomerica, Inc.: Biomerica's inFoods IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal152inFoods IBS Provides Personalized Diet Therapy for Patients Suffering with Irritable Bowel Syndrome (IBS)Research Finds Patients Following a Personalized Diet Therapy Created with inFoods® IBS, Experienced...
► Artikel lesen
Weiter >>
32 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1